Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial

por Seto, T, Ushijima, S, Yamamoto, H, Ito, K, Araki, J, Inoue, Y, Semba, H, Ichinose, Y
Publicado 2006

Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

por Michel, P, Adenis, A, Fiore, F Di, Boucher, E, Galais, M P, Dahan, L, Mirabel, X, Hamidou, H, Raoul, J L, Jacob, J H, Hellot, M F, Prod'Homme, S, Paillot, B
Publicado 2006

Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas

por Ogawa, K, Yoshii, Y, Inoue, O, Toita, T, Saito, A, Kakinohana, Y, Adachi, G, Iraha, S, Tamaki, W, Sugimoto, K, Hyodo, A, Murayama, S
Publicado 2006

Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial

por Chan, A, Martin, M, Untch, M, Gil, M G, Guillem-Porta, V, Wojtukiewicz, M, Kellokumpu-Lehtinen, P, Sommer, H L, Georgoulias, V, Battelli, N, Pawlicki, M, Aubert, D, Bourlard, T, Gasmi, J, Villanova, G, Petruzelka, L
Publicado 2006

Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists

por George, S, Primrose, J, Talbot, R, Smith, J, Mullee, M, Bailey, D, du Boulay, C, Jordan, H
Publicado 2006

Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity

por den Brok, M H M G M, Sutmuller, R P M, Nierkens, S, Bennink, E J, Frielink, C, Toonen, L W J, Boerman, O C, Figdor, C G, Ruers, T J M, Adema, G J
Publicado 2006

Ten-year follow-up results of a randomised controlled study comparing level-I vs level-III axillary lymph node dissection for primary breast cancer

por Kodama, H, Nio, Y, Iguchi, C, Kan, N
Publicado 2006

Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study

por Pittman, K B, Olver, I N, Koczwara, B, Kotasek, D, Patterson, W K, Keefe, D M, Karapetis, C S, Parnis, F X, Moldovan, S, Yeend, S J, Price, T J
Publicado 2006

Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies

por Leyvraz, S, Herrmann, R, Guillou, L, Honegger, H P, Christinat, A, Fey, M F, Sessa, C, Wernli, M, Cerny, T, Dietrich, D, Pestalozzi, B
Publicado 2006

Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy

por Hannemann, J, Kristel, P, van Tinteren, H, Bontenbal, M, van Hoesel, Q G C M, Smit, W M, Nooij, M A, Voest, E E, van der Wall, E, Hupperets, P, de Vries, E G E, Rodenhuis, S, van de Vijver, M J
Publicado 2006

Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms

por Walker, C, Haylock, B, Husband, D, Joyce, K A, Fildes, D, Jenkinson, M D, Smith, T, Broome, J, Kopitzki, K, Plessis, D G du, Prosser, J, Vinjamuri, S, Warnke, P C
Publicado 2006

Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q

por Orsetti, B, Nugoli, M, Cervera, N, Lasorsa, L, Chuchana, P, Rougé, C, Ursule, L, Nguyen, C, Bibeau, F, Rodriguez, C, Theillet, C
Publicado 2006

Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells

por Jones, H E, Gee, J M W, Barrow, D, Tonge, D, Holloway, B, Nicholson, R I
Publicado 2006

Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology

por Carpi, A, Naccarato, A G, Iervasi, G, Nicolini, A, Bevilacqua, G, Viacava, P, Collecchi, P, Lavra, L, Marchetti, C, Sciacchitano, S, Bartolazzi, A
Publicado 2006

Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer

por Radke, I, Götte, M, Kersting, C, Mattsson, B, Kiesel, L, Wülfing, P
Publicado 2006

Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia

por Chatrath, P, Scott, I S, Morris, L S, Davies, R J, Bird, K, Vowler, S L, Coleman, N
Publicado 2006

Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediast...

por Phernambucq, E C J, Biesma, B, Smit, E F, Paul, M A, Tol, A vd, Schramel, F M, Bolhuis, R J, Postmus, P E
Publicado 2006

Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinoma

por Falk, S, Anthoney, A, Eatock, M, Van Cutsem, E, Chick, J, Glen, H, Valle, J W, Drolet, D W, Albert, D, Ferry, D, Ajani, J
Publicado 2006

Cellular senescence in naevi and immortalisation in melanoma: a role for p16?

por Gray-Schopfer, V C, Cheong, S C, Chong, H, Chow, J, Moss, T, Abdel-Malek, Z A, Marais, R, Wynford-Thomas, D, Bennett, D C
Publicado 2006

A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancrea...

por Stathopoulos, G P, Syrigos, K, Aravantinos, G, Polyzos, A, Papakotoulas, P, Fountzilas, G, Potamianou, A, Ziras, N, Boukovinas, J, Varthalitis, J, Androulakis, N, Kotsakis, A, Samonis, G, Georgoulias, V
Publicado 2006